We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Polycystic Ovarian Syndrome Study

Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of Tildacerfont in Adult Subjects with Polycystic Ovary Syndrome (PCOS) and Elevated Adrenal Androgens

woman holding her stomach in pain


AGE: 18 – 40 years old
TYPE: Interventional Study
CONDITION: Polycystic Ovarian Syndrome (PCOS)
LOCATION: University Hospitals Cleveland Medical Center

Learn More About This Research Study

For more information, please contact the study coordinator, Sarah Hornung at 216-983-0832 or complete the online form below.

Study Purpose

The purpose of this research study is to test the safety and behavior of an investigational drug, tildacerfont, in your body.

Who Can Participate

Female participants between 18 to 40 years of age with a confirmed diagnosis of PCOS may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot